TSI is devoted to the treatment of osteoarthritis through the development of products, marketing methodologies and out-licensing opportunities.
TSI combined with our related companies, is a fully vertically integrated manufacturer of glucosamine sulphate finished dosage forms. Having full ownership of production spanning API to the finished dosage forms, we are ideally placed to offer the most secure quality of any market player. Our scientific and technical expertise has been the major contribution which has led to the development and success of our glucosamine and chondroitin series.
With a history of licensed files dating back to 2003 on glucosamine, our core mission is to assist in the treatment osteoarthritis by supporting our licensing partners in the utilisation of our CTD files for regional commercial development.
TSI is now seeking suitable licensees on an exclusive basis throughout the EU, Asia, South and Central Americas and the Middle East.
TSI’s goal is the successful partnership on licensed glucosamine sulphate products in collaboration with our licensing partners. We stand ready to share our extensive glucosamine expertise with the right partner company in order to successfully market and grow licensed glucosamine in your local and regional markets. Our product knowledge and accompanying CTD files which have been active in various EU markets since 2003, coupled with our licensees market knowledge, will enable the future partnerships to realize our goals together.